NCT03615651

Brief Summary

The aim of this study is to determine if and how the "Probiotic Product" affects functional brain responses in healthy subjects during an emotional- and arithmetic stress task, respectively and in terms of microbe-brain-gut interactions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 22, 2018

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 8, 2018

Completed
8 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 16, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 16, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 6, 2018

Completed
Last Updated

August 6, 2018

Status Verified

July 1, 2018

Enrollment Period

5 months

First QC Date

June 8, 2018

Last Update Submit

July 30, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in brain response to validated emotional challenge task (EAT) during functional brain imaging

    Comparing week 4 and 12

Secondary Outcomes (1)

  • Change in brain response to a cognitive challenge task (MIST) during functional brain imaging

    Comparing week 4 and 12

Other Outcomes (15)

  • Change in physical activity assessed by an actigraphy watch (actiwatch)

    Comparing the change in week 0 compared to 4, and 8 compared to 12 (before and in the end of the two intervention periods)

  • Change in sleep quality assessed by an actigraphy watch (actiwatch)

    Comparing the change in week 0 compared to 4, and 8 compared to 12 (before and in the end of the two intervention periods)

  • Change in daily stress levels assessed by an actigraphy watch (actiwatch)

    Comparing the change in week 0 compared to 4, and 8 compared to 12 (before and in the end of the two intervention periods)

  • +12 more other outcomes

Study Arms (2)

Placebo

PLACEBO COMPARATOR

All study participants will receive the study product and the placebo in a randomized, double-blind crossover fashion. Probiotic and placebo products have similar appearance and taste.

Other: Placebo

Probiotic

EXPERIMENTAL

All study participants will receive the study product and the placebo in a randomized, double-blind crossover fashion. Probiotic and placebo products have similar appearance and taste.

Dietary Supplement: Probiotic

Interventions

ProbioticDIETARY_SUPPLEMENT

The Probiotic Formula is commercially available and contains a combination of 3 probiotic strains in addition to other nutrients. The total daily amount of probiotic strain in the product will be no less than 3 billion colony-forming units (CFU) per 3 g powder sachet.

Probiotic
PlaceboOTHER

Placebo intervention.

Placebo

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: Age: 18-65 years, males/females.
  • Signed informed consent -

You may not qualify if:

  • Concurrent or recent treatment with drugs affecting intestinal function or mood, e.g., antidepressants (\< 12 weeks) or antibiotics (\< 12 weeks).
  • Concurrent or recent (\< 4 weeks) use of nutritional supplements or herb products affecting intestinal function or mood (e.g. aloe vera, St. John´s Wort, fibers, prebiotics and probiotics).
  • Diagnosis of major psychiatric or somatic disease. 4) Abuse of alcohol or drugs. 5) Recent (\< 4 weeks) intake of proton pump inhibitors, proton pump inhibitors, PPIs (e.g., omeprazole).
  • \) Asthma. 7) Cardiovascular diseases. 8) Epilepsy. 9) Renal failure. 10) Cerebral bleeding or history of cerebral bleeding. 11) Allergic to latex. 12) Pregnancy (assessed by urine test) or breastfeeding. 13) Claustrophobia. 14) Smoking or using tobacco including snuff. 15) Inability to maintain exercise routine and dietary pattern during the study.
  • \) Consumption of more than 6 cups of coffee/caffeine-containing beverages per day.
  • \) Professional athlete. 18) Dominant left-hand. 19) Medical implant (e.g., pacemaker). 20) Aneurysm clips in the head. 21) Shunts in the head. 22) Grenade-splinter or metal-splinter in the body (e.g., eyes). 23) Metal or electrodes in the body (e.g., temp-catheter, aorta stent, cochlea implant).
  • \) Comprehensive tooth-implants or prothesis. 25) Operated in the head. 26) Operated in the heart. 27) Swallowed a video-capsule. 28) Non-corrected astigmatism. 29) Regular intake of systemic corticosteroids and anti-inflammatory medication (including NSAIDs) during the last three months.
  • \) Visual defect without possibility to use lenses during MRI scanning. 31) Known allergy to milk or soy. 32) Any other reason the investigator feels the subject is not suitable for participation in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Örebro University, Campus USÖ, Örebro University Hospital

Örebro, 70182, Sweden

Location

Related Publications (1)

  • Rode J, Edebol Carlman HMT, Konig J, Repsilber D, Hutchinson AN, Thunberg P, Andersson P, Persson J, Kiselev A, Lathrop Stern L, Salomon B, Mohammed AA, Labus JS, Brummer RJ. Probiotic Mixture Containing Lactobacillus helveticus, Bifidobacterium longum and Lactiplantibacillus plantarum Affects Brain Responses Toward an Emotional Task in Healthy Subjects: A Randomized Clinical Trial. Front Nutr. 2022 Apr 29;9:827182. doi: 10.3389/fnut.2022.827182. eCollection 2022.

MeSH Terms

Conditions

Stress, Psychological

Interventions

Probiotics

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Dietary SupplementsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Robert Brummer, Prof

    Örebro University, Sweden

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, MD

Study Record Dates

First Submitted

June 8, 2018

First Posted

August 6, 2018

Study Start

January 22, 2018

Primary Completion

June 16, 2018

Study Completion

June 16, 2018

Last Updated

August 6, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share

Locations